UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1

Biochemical journal, 1995-12, Vol.312 ( Pt 2) (2), p.637-641

1995

Volltextzugriff (PDF)

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716

Psychopharmacologia, 1996-07, Vol.126 (2), p.165-172

1996

Volltextzugriff (PDF)

The development of cannabinoid antagonists

Current medicinal chemistry, 1999-08, Vol.6 (8), p.745-755

1999

Volltextzugriff (PDF)

Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist

The Journal of pharmacology and experimental therapeutics, 1992-08, Vol.262 (2), p.759

1992

Volltextzugriff (PDF)

Characterization of CB1 Receptors on Rat Neuronal Cell Cultures: Binding and Functional Studies Using the Selective Receptor Antagonist SR 141716A

Journal of neurochemistry, 1997-01, Vol.68 (1), p.402-409

1997

Volltextzugriff (PDF)

Central mediation of the cannabinoid cue: activity of a selective CB1 antagonist, SR 141716A

Behavioural pharmacology, 1996-01, Vol.7 (1), p.65-71

1996

Volltextzugriff (PDF)

Characterization of two cloned human CB1 cannabinoid receptor isoforms

The Journal of pharmacology and experimental therapeutics, 1996-08, Vol.278 (2), p.871

1996

Volltextzugriff (PDF)

The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines

FEBS letters, 1998-04, Vol.425 (3), p.419-425

1998

Volltextzugriff (PDF)

SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor

The Journal of pharmacology and experimental therapeutics, 1998-02, Vol.284 (2), p.644

1998

Volltextzugriff (PDF)

Functional assessment of neuronal cannabinoid receptors in the muscular layers of human ileum and colon

Digestive and liver disease, 2002-04, Vol.34 (4), p.262-269

2002

Volltextzugriff (PDF)

SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization

The Journal of pharmacology and experimental therapeutics, 2004-09, Vol.310 (3), p.905-914

2004

Volltextzugriff (PDF)

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

FEBS letters, 1994-08, Vol.350 (2), p.240-244

1994

Volltextzugriff (PDF)

A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions

The Journal of biological chemistry, 1997-08, Vol.272 (35), p.22330

1997

Volltextzugriff (PDF)

Repeated administration of SR 46349B, a selective 5-hydroxytryptamine2 antagonist, up-regulates 5-hydroxytryptamine2 receptors in mouse brain

Molecular pharmacology, 1993-01, Vol.43 (1), p.84-89

1993

Volltextzugriff (PDF)

Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice

Pharmacology, biochemistry and behavior, 1995-05, Vol.51 (1), p.3-7

1995

Volltextzugriff (PDF)

In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum

British journal of pharmacology, 1998-12, Vol.125 (7), p.1393-1395

1998

Volltextzugriff (PDF)

Regulation of 5-hydroxytryptamine2 (5-HT2) receptor expression in cultured rat aortic smooth muscle cells by SR 46349B, a selective 5-HT2 receptor antagonist

The Journal of biological chemistry, 1994-01, Vol.269 (1), p.396-401

1994

Volltextzugriff (PDF)

An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing

The Journal of biological chemistry, 1995-02, Vol.270 (8), p.3726-3731

1995

Volltextzugriff (PDF)

Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB1 receptors

European journal of pharmacology, 2002-08, Vol.450 (1), p.77-83

2002

Volltextzugriff (PDF)

Interaction of SR 33557 with skeletal muscle calcium channel blocker receptors in the baboon: characterization of its binding sites

The Journal of pharmacology and experimental therapeutics, 1991-05, Vol.257 (2), p.595

1991

Volltextzugriff (PDF)

Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonist

Life sciences (1973), 1995, Vol.56 (23), p.1941-1947

1995

Volltextzugriff (PDF)

Stimulation of Cannabinoid Receptor CB1 Induces krox-24 Expression in Human Astrocytoma Cells

The Journal of biological chemistry, 1995-06, Vol.270 (23), p.13973-13980

1995

Volltextzugriff (PDF)

SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist

The Journal of pharmacology and experimental therapeutics, 1999-02, Vol.288 (2), p.582

1999

Volltextzugriff (PDF)

Modulation of CB1 cannabinoid receptor functions after a long-term exposure to agonist or inverse agonist in the Chinese hamster ovary cell expression system

The Journal of pharmacology and experimental therapeutics, 1998-12, Vol.287 (3), p.1038

1998

Volltextzugriff (PDF)

Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528

Life sciences (1973), 1999, Vol.65 (6), p.627-635

1999

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(45)
Tagungsberichte
(1)

Sprache

Englisch
(44)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

Animals
(31)
Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Receptors, Cannabinoid
(25)
Pharmacology & Pharmacy
(18)
Biological And Medical Sciences
(16)
Pyrazoles - Pharmacology
(15)
Rats
(15)
Humans
(14)
Male
(13)
Biochemistry & Molecular Biology
(12)
Cricetinae
(12)
Mice
(12)
Piperidines - Pharmacology
(12)
Rimonabant
(12)
Cho Cells
(11)
Receptors, Drug - Antagonists & Inhibitors
(11)
Receptors, Drug - Metabolism
(11)
Cyclohexanols - Pharmacology
(9)
In Vitro Techniques
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716

The development of cannabinoid antagonists

Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist

Characterization of CB1 Receptors on Rat Neuronal Cell Cultures: Binding and Functional Studies Using the Selective Receptor Antagonist SR 141716A

Central mediation of the cannabinoid cue: activity of a selective CB1 antagonist, SR 141716A

Characterization of two cloned human CB1 cannabinoid receptor isoforms

The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines

SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor

Functional assessment of neuronal cannabinoid receptors in the muscular layers of human ileum and colon

SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions

Repeated administration of SR 46349B, a selective 5-hydroxytryptamine2 antagonist, up-regulates 5-hydroxytryptamine2 receptors in mouse brain

Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice

In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum

Regulation of 5-hydroxytryptamine2 (5-HT2) receptor expression in cultured rat aortic smooth muscle cells by SR 46349B, a selective 5-HT2 receptor antagonist

An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing

Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB1 receptors

Interaction of SR 33557 with skeletal muscle calcium channel blocker receptors in the baboon: characterization of its binding sites

Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonist

Stimulation of Cannabinoid Receptor CB1 Induces krox-24 Expression in Human Astrocytoma Cells

SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist

Modulation of CB1 cannabinoid receptor functions after a long-term exposure to agonist or inverse agonist in the Chinese hamster ovary cell expression system

Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528

Suchergebnisse filtern